rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Franse aandelen Terug naar discussie overzicht

Euro ressources

788 Posts
Pagina: «« 1 ... 15 16 17 18 19 ... 40 »» | Laatste | Omlaag ↓
  1. [verwijderd] 24 maart 2007 13:35

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Geen supervertaling maar je kunt er iets mee,
    Zal zo even de koppeling neer zetten

    Nederlands:
    De euro Hulpbronnen: Golden Star gaat onder Euro Hulpbronnen voorbij: Golden Star gaat onder de drempel van 5% voorbij. (Cirkel Financiën) - Golden Star Hulpbronnen verklaart als regelen dalend, op 24 januari laatstleden, de drempels van 5% van het kapitaal en het stemrecht van Euro Hulpbronnen overschreden zijn na de overdracht van 250.000 acties aan de Beurs van Toronto. De mijngroep Golden Star Hulpbronnen die op American Voorraad Exchange en Toronto Voorraad Exchange wordt genoteerd, geeft voortaan ongeveer 2,37 miljoen Euro Hulpbronnen in handen hebben, d.w.z 4,70% van het kapitaal en het stemrecht aan.

  4. [verwijderd] 26 maart 2007 08:40

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    en weer een pb
    EURO RESSOURCES S.A.
    Agreement with Golden Star Resources Ltd. on
    Paul Isnard gold exploration properties in French Guiana
    March 26. 2007 - Paris, France and Toronto, Canada: EURO Ressources S.A. (“EURO”) (TSX: EUR; Euronext of the Bourse de Paris: EUR) announces that it has entered into a memorandum of understanding with Golden Star Resources Ltd. (“Golden Star”) (TSX: GSC; AMEX GSS) regarding an amendment to the previous agreement with Golden Star on the Paul Isnard concessions and PER (the “Properties”) held by EURO in French Guiana.
    Highlights of the terms of the agreement are:
    · EURO will receive royalty payments from production on the Properties calculated as to:
    o 10% on the first 2 million ounces of production
    o 5% on the next 3 million ounces of production
    in both cases multiplied by the Market Price of Gold in excess of $400/ounce.
    · By November 2007, Golden Star will spend €1,215,000 on the Paul Isnard exploration permit held by EURO.
    · Golden Star undertakes to complete a feasibility study on at least one project on the Properties within 12 months.
    · Subject to a positive feasibility study, Golden Star will commence commercial production within 30 months.
    · In the event of commercial production being delayed, Golden Star will pay advance royalties of $1,000,000 per annum.
    · Golden Star confirms the full forgiveness of the remaining $8.5 million of debt that was outstanding from EURO’s reorganization in 2004.
    James H Dunnett, Directeur-Général of EURO commented: “We are most pleased that Golden Star has been able to make the commitments required to move the Paul Isnard Properties forward with an active exploration program and prospective production. A royalty on production is entirely in keeping with our intention to focus on this type of exposure to the gold price with a high quality operator such as Golden Star. I believe this is good news for French Guiana and excellent news for our shareholders who have waited patiently for progress on Paul Isnard.”
    Additionally, Golden Star has granted an option to EURO to purchase the residual payment obligation due by EURO to Golden Star under the Rosebel Royalty purchase agreement. This Option is for a cash payment of $4,150,000 on or before June 30, 2007 with a right to extend the option period to December 31, 2007.
    EURO’s Directeur-Général, James H Dunnett, stated: “These additional purchase payments to Golden Star are related to future production from Rosebel. Although payment is not expected to commence until 2010 or later, the total obligations could amount to $30 million with full production of the 7 million ounces of the Rosebel Royalty. We are pleased we have been able to agree on a fixed amount for early payment, particularly with the continuing increase in resources at Rosebel.”

    EURO also announces that IAMGold Corporation (“IAMGold”) (TSX: IMG; NYSE: IAG) has confirmed its intention to consider increasing production at the Rosebel gold mine to 400,000 ounces of gold production per year.
    In a letter to EURO dated March 20, 2007, Joe Conway, IAMGold’s President and CEO is quoted as stating, in respect of the Rosebel gold mine “We are looking at an expansion scenario and in the second half of the year we should be in a position to make a decision on whether to increase throughput and take production from 300,000 ounces to 400,000 ounces per year”.
    IAMGold also clarified in its letter that the $25 million in budgeted capital expenditures for Rosebel in the 2007 year referred to in the conference telephone call held March 15, 2007 is not related solely to costs associated with the expansion of the Rosebel mine but includes costs relating to capitalized exploration expenses. IAMGold further confirmed in its letter that any decision to proceed with the Rosebel expansion is subject to a positive feasibility study and states that this process has not been commenced.
    James H. Dunnett, EURO’s Directeur-Général, said: “We are very pleased that IAMGold has clarified and confirmed its position on an expansion of production at Rosebel to 400,000 ounces per year. An expansion of this magnitude would have a significantly beneficial impact on our future revenue from the Rosebel Royalty. IAMGold’s comments and the continued expansion of resources at Rosebel support our expectation that an expansion of production is likely.”
    About EURO
    EURO is a French company, presently focused on acquiring and holding royalties and similar interests on operating gold mines, and has recently announced that it has signed a letter of intent to acquire Patricia Mines Corp. EURO also holds certain gold mineral rights in French Guiana. EURO has approximately 50.5 million shares outstanding.
    Statements Regarding Forward-Looking Information: Some statements contained in this news release are forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain and involve risks and uncertainties that could cause actual results to differ materially. Such statements include comments regarding IAMGold’s intentions to expand production at the Rosebel mine and of the Company to acquire additional royalty or mineral interests. There can be no assurance that future developments affecting the Company or the Rosebel gold mine will be those anticipated by management.
    Not for distribution to United States newswire services or for dissemination in the United States. The securities referred to herein have not been registered under the US Securities Act of 1933 and may not be offered or sold in the United States or to a US person absent registration or an applicable exemption from registration.

    Additional information relating to EURO Ressources S.A. is available on SEDAR at www.sedar.com. Further requests for information should be addressed to
  5. [verwijderd] 26 maart 2007 08:43

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    en een leuke zin vind ik . I believe this is good news for French Guiana and excellent news for our shareholders who have waited patiently for progress on Paul Isnard"

    knalle dus vandaag
  18. [verwijderd] 27 maart 2007 16:17

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    misschien interessant om te lezen voor mensen die dit aandeel hebben , is het verhaal op Inveztor over Victoria dat gisteren 30 % van de beurskoers verloor in canada.
    Hier zijn ook insiders vooraf aan het verkopen geweest.Volgens Inveztor(Middenkoop) zijn de gegevens gisteren overigens verkeerd geinterpreteerd en zou men in moeten stappen,maar misschien moet de conclusie zijn,dat je je echt moet verdiepen in deze handel of er uit weg blijven.

    ik heb geen positie in beide aandelen overigens en ook geen plannen.
788 Posts
Pagina: «« 1 ... 15 16 17 18 19 ... 40 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.019
AB InBev 2 5.506
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.704
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.714
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.866
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.882
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.269
AMG 971 133.478
AMS 3 73
Amsterdam Commodities 305 6.691
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.009
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.781
Arcelor Mittal 2.033 320.724
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.305
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.190
ASML 1.766 107.554
ASR Nederland 21 4.498
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.675
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392